<DOC>
	<DOCNO>NCT00181012</DOCNO>
	<brief_summary>This study evaluate benefit lidocaine perfusion cancer relate visceral pain resistant morphinics . It efficacy study adult child randomize prospective study .</brief_summary>
	<brief_title>Benefit Lidocaine Perfusion Cancer Related Visceral Pain Resistant Morphinics</brief_title>
	<detailed_description />
	<mesh_term>Visceral Pain</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<criteria>Patients suffer cancer type , stage , hospitalize Institut Gustave Roussy Aged 6 14 year old ( group A ) 15 70 year old ( adult ) Presenting visceral pain due neurotoxic chemotherapy , due tumoral mass peritoneal carcinosis Pain resistant morphinic treatment Cardiac trouble , clinical cardiac insufficiency , history myocardial infarction ( MI ) less 3 month Neurological : noncontrolled epilepsy , encephalopathy , dementia Severe hepatic insufficiency Severe renal insufficiency Respiratory insufficiency Patients surgery postoperative period Known deficit G6PD , alanine exposure , sulphamide treatment Porphyria Weight &gt; 80 kg</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2006</verification_date>
	<keyword>Cancer Related Visceral Pain Resistant Morphinics</keyword>
</DOC>